Annovis Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,220 | -6,283 | -6,735 | -4,388 |
EBIT | -6,735 | |||
Net Income | -6,220 | -5,537 | -5,865 | -12,638 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,105,889 | -8,099,164 | -8,285 | -3,201 |
Cash | 17,130,286 | 22,236 | 10,551 | 12,636 |
Basic Shares | 19,486 | 12,235 | 13,795 | 12,976 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -22,737 | -45,035 | -25,511 | -14,500 |
EBIT | -45,035 | -25,511 | -29,037 | |
Net Income | -24,590,375 | -56,204 | -25,145 | -14,487 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 37,611 | |||
Free Cash Flow | -21,894,604 | -39,967 | -17,312 | -9,132 |
Cash | 10,551 | 5,754 | 28,377 | 45,686 |
Basic Shares | 12,235 | 9,023 | 8,162 | 7,626 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.32 |
2025-03-31 | -$0.32 |
2024-12-31 | -$0.43 |
